Literature DB >> 18284609

Transcriptional activation of human mu-opioid receptor gene by insulin-like growth factor-I in neuronal cells is modulated by the transcription factor REST.

Andrea Bedini1, Monica Baiula, Santi Spampinato.   

Abstract

The human mu-opioid receptor gene (OPRM1) promoter contains a DNA sequence binding the repressor element 1 silencing transcription factor (REST) that is implicated in transcriptional repression. We investigated whether insulin-like growth factor I (IGF-I), which affects various aspects of neuronal induction and maturation, regulates OPRM1 transcription in neuronal cells in the context of the potential influence of REST. A series of OPRM1-luciferase promoter/reporter constructs were transfected into two neuronal cell models, neuroblastoma-derived SH-SY5Y cells and PC12 cells. In the former, endogenous levels of human mu-opioid receptor (hMOPr) mRNA were evaluated by real-time PCR. IGF-I up-regulated OPRM1 transcription in: PC12 cells lacking REST, in SH-SY5Y cells transfected with constructs deficient in the REST DNA binding element, or when REST was down-regulated in retinoic acid-differentiated cells. IGF-I activates the signal transducer and activator of transcription-3 signaling pathway and this transcription factor, binding to the signal transducer and activator of transcription-1/3 DNA element located in the promoter, increases OPRM1 transcription. We propose that a reduction in REST is a critical switch enabling IGF-I to up-regulate hMOPr. These findings help clarify how hMOPr expression is regulated in neuronal cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18284609     DOI: 10.1111/j.1471-4159.2008.05303.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

Review 1.  Transcriptional and epigenetic regulation of opioid receptor genes: present and future.

Authors:  Li-Na Wei; Horace H Loh
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

Review 2.  Epigenetics of µ-opioid receptors: intersection with HIV-1 infection of the central nervous system.

Authors:  Patrick M Regan; Rajnish S Dave; Prasun K Datta; Kamel Khalili
Journal:  J Cell Physiol       Date:  2012-07       Impact factor: 6.384

3.  DS-70, a novel and potent α4 integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs.

Authors:  Samantha Deianira Dattoli; Monica Baiula; Rossella De Marco; Andrea Bedini; Michele Anselmi; Luca Gentilucci; Santi Spampinato
Journal:  Br J Pharmacol       Date:  2018-09-17       Impact factor: 8.739

4.  Sex-specific linkage scans in opioid dependence.

Authors:  Bao-Zhu Yang; Shizhong Han; Henry R Kranzler; Abraham A Palmer; Joel Gelernter
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-10-20       Impact factor: 3.568

5.  Positive transcriptional regulation of the human micro opioid receptor gene by poly(ADP-ribose) polymerase-1 and increase of its DNA binding affinity based on polymorphism of G-172 -> T.

Authors:  Takeshi Ono; Toshio Kaneda; Akihiro Muto; Tadashi Yoshida
Journal:  J Biol Chem       Date:  2009-05-15       Impact factor: 5.157

6.  Age-Dependent Neuroimmune Modulation of IGF-1R in the Traumatic Mice.

Authors:  Hui Zhao; Xiaocong Zhao; Xiaoding Cao; Gencheng Wu
Journal:  Immun Ageing       Date:  2012-05-28       Impact factor: 6.400

7.  Side chain effect in the modulation of αvβ35β1 integrin activity via clickable isoxazoline-RGD-mimetics: development of molecular delivery systems.

Authors:  Lucia Ferrazzano; Monica Baiula; Dario Corbisiero; Eleonora Potenza; Samantha Deianira Dattoli; Santi Spampinato; Laura Belvisi; Monica Civera; Alessandra Tolomelli
Journal:  Sci Rep       Date:  2020-05-04       Impact factor: 4.379

8.  Ablation of STAT3 in Purkinje cells reorganizes cerebellar synaptic plasticity in long-term fear memory network.

Authors:  Jeong-Kyu Han; Sun-Ho Kwon; Yong Gyu Kim; Jaeyong Choi; Jong-Il Kim; Yong-Seok Lee; Sang-Kyu Ye; Sang Jeong Kim
Journal:  Elife       Date:  2021-01-18       Impact factor: 8.140

9.  Leukocyte Integrin Antagonists as a Novel Option to Treat Dry Age-Related Macular Degeneration.

Authors:  Monica Baiula; Alberto Caligiana; Andrea Bedini; Junwei Zhao; Federica Santino; Martina Cirillo; Luca Gentilucci; Daria Giacomini; Santi Spampinato
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

10.  Functional Selectivity and Antinociceptive Effects of a Novel KOPr Agonist.

Authors:  Andrea Bedini; Lorenzo Di Cesare Mannelli; Laura Micheli; Monica Baiula; Gabriela Vaca; Rossella De Marco; Luca Gentilucci; Carla Ghelardini; Santi Spampinato
Journal:  Front Pharmacol       Date:  2020-03-05       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.